Angiotensin-converting enzyme inhibition reduces food intake and weight gain and improves glucose tolerance in melanocortin-4 receptor deficient female rats

Physiology and Behavior

Volumn 121, Issue , 2013, Pages 43-48

  Mul, Joram D ^a   Seeley, Randy J ^a   Woods, Stephen C ^a   Begg, Denovan P ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

ACE inhibitor; Captopril; MC4R; Melanocortin; Renin angiotensin system

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MELANOCORTIN 4 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FLUID INTAKE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INSULIN TOLERANCE TEST; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RAT; WEIGHT GAIN; WEIGHT REDUCTION;

ACE INHIBITOR; CAPTOPRIL; MC4R; MELANOCORTIN; RENIN-ANGIOTENSIN SYSTEM;

ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; CAPTOPRIL; EATING; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, TRANSGENIC; RECEPTOR, MELANOCORTIN, TYPE 4; TIME FACTORS;

EID: 84887172664     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2013.01.013     Document Type: Article

References (35)

1. Farooqi I.S., Yeo G.S., Keogh J.M., Aminian S., Jebb S.A., Butler G., et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000, 106:271-279.
2. Marsh D.J., Hollopeter G., Huszar D., Laufer R., Yagaloff K.A., Fisher S.L., et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 1999, 21:119-122.
3. Ollmann M.M., Wilson B.D., Yang Y.K., Kerns J.A., Chen Y., Gantz I., et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278:135-138.
4. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
5. Mul J.D., van Boxtel R., Bergen D.J., Brans M.A., Brakkee J.H., Toonen P.W., et al. Melanocortin receptor 4 deficiency affects body weight regulation, grooming behavior, and substrate preference in the rat. Obesity (Silver Spring) 2012, 20:612-621.
6. Farooqi I.S., Keogh J.M., Yeo G.S., Lank E.J., Cheetham T., O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003, 348:1085-1095.
7. Yeo G.S., Farooqi I.S., Aminian S., Halsall D.J., Stanhope R.G., O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998, 20:111-112.
8. Balthasar N., Dalgaard L.T., Lee C.E., Yu J., Funahashi H., Williams T., et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005, 123:493-505.
9. Tao Y.X. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev 2010, 31:506-543.
10. Begg D.P., Woods S.C. The central insulin system and energy balance. Handb Exp Pharmacol 2012, 111-129.
11. Morton G.J., Schwartz M.W. The NPY/AgRP neuron and energy homeostasis. Int J Obes (Lond) 2001, 25:S56-S62.
12. de Kloet A.D., Krause E.G., Woods S.C. The renin angiotensin system and the metabolic syndrome. Physiol Behav 2010, 100:525-534.
13. Weisinger R.S., Begg D.P., Jois M. Antagonists of the renin-angiotensin system and the prevention of obesity. Curr Opin Investig Drugs 2009, 10:1069-1077.
14. Putnam K., Shoemaker R., Yiannikouris F., Cassis L.A. The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am J Physiol Heart Circ Physiol 2012, 302:H1219-H1230.
15. Weisinger R.S., Begg D.P., Chen N., Jois M., Mathai M.L., Sinclair A.J. The problem of obesity: is there a role for antagonists of the renin-angiotensin system?. Asia Pac J Clin Nutr 2007, 16(Suppl. 1):359-367.
16. Weisinger H.S., Begg D.P., Egan G.F., Jayasooriya A.P., Lie F., Mathai M.L., et al. Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats. Physiol Behav 2008, 93:820-825.
17. Weisinger R.S., Stanley T.K., Begg D.P., Weisinger H.S., Spark K.J., Jois M. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiol Behav 2009, 98:192-197.
18. Premaratna S.D., Manickam E., Begg D.P., Rayment D.J., Hafandi A., Jois M., et al. Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice. Int J Obes (Lond) 2012, 36:233-243.
19. Miesel A., Muller-Fielitz H., Johren O., Vogt F.M., Raasch W. Double blockade of angiotensin II (AT(1))-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats. Br J Pharmacol 2012, 165:2721-2735.
20. Muller-Fielitz H., Landolt J., Heidbreder M., Werth S., Vogt F.M., Johren O., et al. Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARgamma target gene regulation. Endocrinology 2012, 153:1103-1115.
21. Fujisaka S., Usui I., Kanatani Y., Ikutani M., Takasaki I., Tsuneyama K., et al. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice. Endocrinology 2011, 152:1789-1799.
22. Jayasooriya A.P., Mathai M.L., Walker L.L., Begg D.P., Denton D.A., Cameron-Smith D., et al. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci U S A 2008, 105:6531-6536.
23. Massiera F., Seydoux J., Geloen A., Quignard-Boulange A., Turban S., Saint-Marc P., et al. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 2001, 142:5220-5225.
24. Yvan-Charvet L., Massiera F., Lamande N., Ailhaud G., Teboul M., Moustaid-Moussa N., et al. Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue. Endocrinology 2009, 150:1421-1428.
25. Massiera F., Bloch-Faure M., Ceiler D., Murakami K., Fukamizu A., Gasc J.M., et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001, 15:2727-2729.
26. Kalupahana N.S., Massiera F., Quignard-Boulange A., Ailhaud G., Voy B.H., Wasserman D.H., et al. Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance. Obesity (Silver Spring) 2012, 20:48-56.
27. Kim S., Soltani-Bejnood M., Quignard-Boulange A., Massiera F., Teboul M., Ailhaud G., et al. The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin-angiotensin system. J Biomed Biotechnol 2006, 2006:27012.
28. de Kloet A.D., Krause E.G., Kim D.H., Sakai R.R., Seeley R.J., Woods S.C. The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis. Endocrinology 2009, 150:4114-4123.
29. Mul J.D., Begg D.P., Alsters S.I., Haaften G., Duran K.J., D'Alessio D.A., et al. Effect of vertical sleeve gastrectomy in melanocortin receptor 4-deficient rats. Am J Physiol Endocrinol Metab 2012, 303:E103-E110.
30. Yamamoto R., Akazawa H., Fujihara H., Ozasa Y., Yasuda N., Ito K., et al. Angiotensin II type 1 receptor signaling regulates feeding behavior through anorexigenic corticotropin-releasing hormone in hypothalamus. J Biol Chem 2011, 286:21458-21465.
31. Grobe J.L., Grobe C.L., Beltz T.G., Westphal S.G., Morgan D.A., Xu D., et al. The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab 2010, 12:431-442.
32. Yvan-Charvet L., Even P., Bloch-Faure M., Guerre-Millo M., Moustaid-Moussa N., Ferre P., et al. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 2005, 54:991-999.
33. de Kloet A.D., Krause E.G., Scott K.A., Foster M.T., Herman J.P., Sakai R.R., et al. Central angiotensin II has catabolic action at white and brown adipose tissue. Am J Physiol Endocrinol Metab 2011, 301:E1081-E1091.
34. Peterson C.M., Morioka N., Zhu C., Ryan J.W., LeMaire W.J. Angiotensin-converting enzyme inhibitors have no effect on ovulation and ovarian steroidogenesis in the perfused rat ovary. Reprod Toxicol 1993, 7:131-135.
35. Irani B.G., Xiang Z., Moore M.C., Mandel R.J., Haskell-Luevano C. Voluntary exercise delays monogenetic obesity and overcomes reproductive dysfunction of the melanocortin-4 receptor knockout mouse. Biochem Biophys Res Commun 2005, 326:638-644.